| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.71B | 141.50% |
| Operating expense | — | — |
| Net income | -297.77M | -71.41% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 6HN.F returned -47.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -3.5% |
| 1 year | -47.3% |
| 5 years | -22.8% |
| All-time high | €8.75 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 6HN.F would be worth today ›No. Everest Medicines Limited has not paid a dividend in the past 12 months.
Everest Medicines Limited is part of the Healthcare sector.
Everest Medicines Limited has a market cap of 1.37B EUR, based on the latest quote.